Evidence map›Paper›PMID 34706286›Full record

Observational studyInternational journal of cardiology2021

In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19.

Hernan Mejia-Renteria, Alejandro Travieso, Adam Sagir, Eduardo Martínez-Gómez, Angela Carrascosa-Granada, Takumi Toya, Iván J Núñez-Gil, Vicente Estrada, Amir Lerman, Javier Escaned

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in International journal of cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Utilizing Invasive Coronary Functional Testing in a Coronary Microvascular and Vasomotor Dysfunction Program: Methods and Considerations.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Hernan Mejia-RenteriaHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain. Electronic address: hmejiarenteria@gmail.com.
Alejandro TraviesoHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Adam SagirBar-Ilan University, Faculty of Medicine, Safed, Israel.
Eduardo Martínez-GómezHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Angela Carrascosa-GranadaHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Takumi ToyaMayo Clinic, Rochester, MN, United States.
Iván J Núñez-GilHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Vicente EstradaHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Amir LermanMayo Clinic, Rochester, MN, United States.
Javier EscanedHospital Clínico San Carlos, IDISSC and Universidad Complutense de Madrid, Madrid, Spain.
Universidad Complutense de Madrid · ESHospital Clínico San Carlos · ESMayo Clinic in Arizona · USBar-Ilan University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndothelial dysfunction is one of the underlying mechanisms to vascular and cardiac complications in patients with COVID-19. We sought to investigate the systemic vascular endothelial function and its temporal changes in COVID-19 patients from a non-invasive approach with reactive hyperemia peripheral arterial tonometry (PAT).

methodsThis is a prospective, observational, case-control and blinded study. The population was comprised by 3 groups: patients investigated during acute COVID-19 (group 1), patients investigated during past COVID-19 (group 2), and controls 1:1 matched to COVID-19 patients by demographics and cardiovascular risk factors (group 3). The natural logarithmic scaled reactive hyperemia index (LnRHI), a measure of endothelium-mediated dilation of peripheral arteries, was obtained in all the participants and compared between study groups.

results144 participants were enrolled (72 COVID-19 patients and 72 matched controls). Median time from COVID-19 symptoms to PAT assessment was 9.5 and 101.5 days in groups 1 and 2, respectively. LnRHI was significantly lower in group 2 compared to both group 1 and controls (0.53 ± 0.23 group 2 vs. 0.72 ± 0.26 group 1, p = 0.0043; and 0.79 ± 0.23 in group 3, p < 0.0001). In addition, within group 1, it was observed a markedly decrease in LnRHI from acute COVID-19 to post infection stage (0.73 ± 0.23 vs. 0.42 ± 0.26, p = 0.0042).

conclusionsThis study suggests a deleterious effect of SARS-CoV-2 infection on systemic vascular endothelial function. These findings open new venues to investigate the clinical implication and prognostic role of vascular endothelial dysfunction in COVID-19 patients and post-COVID syndrome using non-invasive techniques.

Indexed as

COVID-19HyperemiaVascular DiseasesEndothelium, VascularHumansManometryProspective StudiesSARS-CoV-2COVID-19SARS-CoV-2Systemic vascular endothelial function

Identifiers

PMID34706286
PMCPMC8542397
OpenAlexW3209335846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.